Lead party: European Bank for Reconstruction and Development (EBRD) (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: MS Pharma Partners Holding W.L.L (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria, Sudan
Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Deal amount: US$50m
Lead investor/buyer: European Bank for Reconstruction and Development (EBRD) · Investors/buyers: European Bank for Reconstruction and Development (EBRD)
Legal advisers: not identified in the source record.
Source: announced 9 September 2016. Original announcement: ebrd.com.


